HealthQuill DNA
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Pharma

AI-designed universal vaccine against coronavirus passes human trial

HQ Team June 9, 2026: Researchers at the University of Cambridge and UK biotech firm DIOSynVax have designed a vaccine targeting the entire.

Read More
High antibiotic use may have a long-term effect on a person’s gut microbiome, and certain antibiotics can cause changes in the community of bacteria living in the gut for up to eight years, a Swedish study reveals.
Drugs Health Research

Certain antibiotics cause serious harm to gut microbiome: Swedish researchers

High antibiotic use may have a long-term effect on a person’s gut microbiome, and certain antibiotics can cause changes in the community of.

Read More
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
Health Medical Research

A blood test can reveal your short-term survival period: Study

Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.

Read More
A new weapon to kill superbugs may be on the horizon after Harvard researchers created a synthetic compound called cresomycin.
Drugs Health

HIV’s shape-shifting protein reveals clues for smarter drug design

A study from the Salk Institute has found HIV’s ability to hijack human cells, uncovering a shape-shifting viral protein that could transform treatments for the.

Read More
AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live longer, company data from an end-stage study reveals.
Drugs Health Pharma

AstraZeneca’s therapy for a type of lung cancer helps patients live longer 

HQ Team July 21, 2025: AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live.

Read More
Illumina, Inc. will acquire California-based SomaLogic, a company that is involved in identifying and quantifying proteins within a cell, for $425 million, according to a company statement.
Drugs Health Pharma

Illumina to acquire proteomics company SomaLogic in $425 million all cash deal

HQ Team June 23, 2025: Illumina, Inc. will acquire California-based SomaLogic, a company that is involved in identifying and quantifying proteins within a.

Read More
Eli Lilly and Company will acquire gene-editing startup Verve Therapeutics, Inc. for up to $1.3 billion to pocket an early-stage experimental therapy and to develop once-in-a-lifetime treatments for cardiovascular diseases.
Drugs Health Pharma

Eli Lilly to buy Verve for $1.3 billion, expands heart therapy segment

HQ Team June 19, 2025: Eli Lilly and Company will acquire gene-editing startup Verve Therapeutics, Inc. for up to $1.3 billion to pocket an.

Read More
Stanford University, along with other researchers, has developed a set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy — a tool which may lead to new gene therapies to treat Parkinson’s, Alzheimer’s and neurogenerative diseases.
Drugs Health Research

Scientists make gene ‘truck’ to unload genetic package in brain, spine

HQ Team May 30, 2025: Stanford University, along with other researchers, has developed a set of gene delivery systems that can reach different.

Read More
Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases as well as traumatic injury.
Uncategorized

‘Mailman’ gene-editing tool carries molecule to exact ‘zip code’

HQ Team May 24, 2025: Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases.

Read More
Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a Worker Adjustment and Retraining Act filing with the Massachusetts government.
Drugs Health Pharma

US-based Tome Biosciences to retrench 131 employees 

Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.

Read More